128
Palvella Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
73.4
FY23:
7.55
FY24:
88.2
FY25:
59.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
25.9
FY22:
22.1
FY23:
0
FY24:
0
FY25:
0.57
Total assets
Change from FY21 to FY25
millions USD
FY21:
154
FY22:
95.5
FY23:
7.55
FY24:
88.2
FY25:
59.6
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
50.6
FY22:
36.6
FY23:
2.36
FY24:
12.0
FY25:
11.3
(negative)
Change from FY21 to FY25
millions USD
FY21:
52.2
FY22:
31.0
FY23:
9.07
FY24:
13.6
FY25:
20.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
50.8
FY22:
27.9
FY23:
−74.5
FY24:
62.6
FY25:
28.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
154
FY22:
95.5
FY23:
–
FY24:
88.2
FY25:
59.6
All amounts in millions USD